Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
o2h Ventures investment portfolio
o2h Ventures has made numerous investments in companies such as Turbine Simulated Cell Technologies, Stratosvir, and Kuano within the Biotech sector.
unknown
Portfolio
17
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (17)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Alevin Therapeutics Limited | Healthcare & Life Sciences | Cambridge | Confirmed | 2026-03-10 |
| Camgene Therapeutics Limited CAMGENE THERAPEUTICS LIMITED is a biotechnology company focused on developing RNA-based treatments for hearing loss. They utilize lipid nanoparticle-based mRNA technology to target ear cells, aiming to regenerate nerve cells and restore natural hearing for patients with various forms of hearing impairment. | BiotechHealth Tech | Cambridge | Confirmed | 2025-06-06 |
Shareholding changes (14)
O2h Nominees Limited's positions across portfolio companies2026
- ORDINARY 113,977 → 131,835
- B ORDINARY SHARES 2,330 → 6,755
Articles (6)
- 11 Jun 2026
- Liquid Ventures I LP joins Cardiatec Biosciences as LQD Ventures exits10 Jun 2026Cardiatec Biosciences
- 9 Jun 2026
- Camgene Therapeutics secures £260k Series A funding for hearing loss treatments19 May 2026Camgene Therapeutics
- 12 May 2026
- Turbine Simulated Cell Technologies raises £22.8m Series B for AI drug discovery platform9 May 2026Turbine Simulated Cell Technologies